Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

By Mitral Foundation FEATURING Richard Whitlock, Randolph Martin

765 views

August 11, 2023

Randolph Martin, MD, and Richard Whitlock, MD discuss the AtriCure LeAAPS (Left Atrial Appendage Exclusion ...
read more ↘ for Prophylactic Stroke Reduction Trial) trial which Dr. Whitlock believes will answer whether left atrial appendage occlusion in patients undergoing cardiac surgery for another indication is safe and effective for stroke prevention.

The trial will randomize 6,500 patients in 250 centers around the world who are undergoing surgery via sternotomy. Dr. Whitlock adds that this robust data will allow for a new level of confidence in this treatment – possibly resulting in prevention of tens of thousands of strokes around the world.
↖ read less

Comments 0